Alleviating VLDL overproduction is an important mechanism for Laminaria japonica polysaccharide to inhibit atherosclerosis in LDLr−/− mice with diet-induced insulin resistance

Molecular Nutrition and Food Research

Volumn 61, Issue 4, 2017, Pages

  Zha, Xue Qiang ^a   Zhang, Wei Nan ^a   Peng, Fu Hua ^a   Xue, Lei ^a   Liu, Jian ^a   Luo, Jian Ping ^a  

^a HEFEI UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Atherosclerosis; Insulin resistance; Laminaria japonica; Polysaccharide; Very low density lipoprotein

Indexed keywords

INSR PROTEIN, HUMAN; INSULIN; INSULIN RECEPTOR; LDLR PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; LOW DENSITY LIPOPROTEIN RECEPTOR; POLYSACCHARIDE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL; ATHEROSCLEROSIS; CHEMISTRY; GENETICS; INSULIN RESISTANCE; LAMINARIA; LIPID DIET; MALE; METABOLISM; MOUSE; ORAL DRUG ADMINISTRATION; PHYSIOLOGY;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, CD; ATHEROSCLEROSIS; DIET, HIGH-FAT; INSULIN; INSULIN RESISTANCE; LAMINARIA; LIPOPROTEINS, VLDL; MALE; MICE; POLYSACCHARIDES; RECEPTOR, INSULIN; RECEPTORS, LDL;

EID: 85013344000     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600456     Document Type: Article

References (47)

1. Weber, C., Noels, H., Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 2011, 17, 1410–1422.
2. McGillicuddy, F. C., Roche, H. M., Nutritional status, genetic susceptibility, and insulin resistance—important precedents to atherosclerosis. Mol. Nutr. Food Res. 2012, 56, 1173–1184.
3. Adiels, M., Olofsson, S. O., Taskinen, M. R., Boré, J., Overproduction of very low–density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 1225–1236.
4. Ruderman, N. B., Carling, D., Prentki, M., Cacicedo, J. M., AMPK, insulin resistance, and the metabolic syndrome. J. Clin. Invest. 2013, 123, 2764–2772.
5. Steiner, G., Lewis, G. F., Hyperinsulinemia and triglyceride-rich lipoproteins. Diabetes 1996, 45(Suppl. 3), S24–S26.
6. Han, S., Liang, C. P, Westerterp, M., Senokuchi, T. et al., Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. J. Clin. Invest. 2009, 119, 1029–1041.
7. Haas, M. E., The regulation of ApoB metabolism by insulin. Trends Endocrin. Met. 2013, 24, 391–397.
8. Sidiropoulos, K. G., Insulin inhibition of apolipoprotein B mRNA translation is mediated via the PI-3 kinase/mTOR signaling cascade but does not involve internal ribosomal entry site (IRES) initiation. Arch. Biochem. Biophys. 2007, 465, 380–388.
9. Strong, A., Ding, Q., Edmondson, A. C, Millar, J. S. et al., Hepatic Sortilin regulates both apolipoprotein B secretion and LDL catabolism. J. Clin. Invest. 2012, 122, 2807–2816.
10. Choi, S. H., Ginsberg, H. N., Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. Trends Endocrin. Met. 2011, 22, 353—363.
11. Kamagate, A., Qu, S., Perdomo, G., Su, D. et al., FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J. Clin. Invest. 2008, 118, 2347–2364.
12. Tsai, C.-W., Liu, K.-L., Lin, Y.-R., Kuo, W.-C., The mechanisms of carnosic acid attenuates tumor necrosis factor-α-mediated inflammation and insulin resistance in 3T3-L1 adipocytes. Mol. Nutr. Food Res. 2014, 58, 654–664.
13. Zha, X. Q., Xiao, J. J., Zhang, H. N., Wang, J. H. et al., Polysaccharides in Laminaria japonica (LP): extraction, physicochemical properties and their hypolipidemic activities in diet-induced mouse model of atherosclerosis. Food Chem. 2012, 134, 244–252.
14. Zha, X. Q., Xue, L., Zhang, H. L., Asghar, M. N. et al., Molecular mechanism of a new Laminaria japonica polysaccharide on the suppression of macrophage foam cell formation via regulating cellular lipid metabolism and suppressing cellular inflammation. Mol. Nutr. Food Res. 2015, 59, 2008–2021.
15. Kim, K. J., Lee, O. H, Han, C. K., Hong, H. D., Acidic polysaccharide extracts from Gastrodia Rhizomes suppress the atherosclerosis risk index through inhibition of the serum cholesterol composition in Sprague Dawley rats fed a high-fat diet. Int. J. Mol. Sci. 2012, 13, 1620–1631.
16. Wu, F., Meng, G. L., Chang, S. S., Xu, J. L., The anti-atherosclerotic effect of Ganoderma lucidum polysaccharides via down-regulation of vascular NADPH oxidases expression in atherosclerosis rats. Chin. Pharmacol. Bull. 2012, 28, 944–947.
17. Lichtman, A. H., Clinton, S. K., Iiyama, K., Connelly, P. W. et al., Hyperlipidemia and atherosclerotic lesion development in LDL receptor–deficient mice fed defined semipurified diets with and without cholate. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 1938–1944.
18. Forrest, L. M., Lough, C. M., Chung, S., Boudyguina, E. Y. et al., Echium oil reduces plasma triglycerides by increasing intravascular lipolysis in apob100-only low density lipoprotein (LDL) receptor knockout mice. Nutrients 2013, 5, 2629–2645.
19. Fang, Q., Wang, J. F., Zha, X. Q., Cui, S. H. et al., Immunomodulatory activity on macrophage of a purified polysaccharide extracted from Laminaria japonica. Carbohydr. Polym. 2015, 134, 66–73.
20. Schreyer, S. A., Vick, C., Lystig, T. C., Mystkowski, P. et al., LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am. J. Physiol-Endoc. M. 2002, 282, E207–E214.
21. VanderLaan, P. A., Reardon, C. A., Thisted, R. A., Getz, G. S., VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. J. Lipid Res. 2009, 50, 376–385.
22. Wang, Y., Gusarova, V., Banfi, S., Gromada, J. et al., Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion. J. Lipid Res. 2015, 56, 1296–1307.
23. Taher, J., Baker, C. L., Cuizon, C., Masoudpour, H. et al., GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance. Mol. Metab. 2014, 3, 823–833.
24. Carneiro, M. M., Miname, M. H., Gagliardi, A. C., Pereira, C. et al., The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: study with artificial emulsions. Atherosclerosis 2012, 221, 268–274.
25. Foley, E. M., Gordts, P. L., Stanford, K. I., Gonzales, J. C. et al. Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 2065–2074.
26. −/− mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels. J. Lipid Res. 2010, 51, 2655–2663.
27. Kulinski, A., Rustaeus, S., Vance, J. E., Microsomal triacylglycerol transfer protein is required for lumenal accretion of triacylglycerol not associated with ApoB, as well as for ApoB lipidation. J. Biol. Chem. 2002, 277, 31516–31525.
28. Sundaram, M., Zhong, S., Khalil, M. B., Zhou, H. et al., Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia. J. Lipid Res. 2010, 51, 1524–1534.
29. Phung, T. L., Roncone, A., Jensen, K. L., Sparks, C. E. et al., Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum. J. Biol. Chem. 1997, 272, 30693–30702.
30. Taniguchi, C. M., Emanuelli, B., Kahn, C. R., Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 2006, 7, 85–96.
31. Li, S., Brown, M. S., Goldstein, J. L., Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl. Acad. Sci. USA 2010, 107, 3441–3446.
32. González-Rodríguez, Á., Santamaría, B., Mas-Gutierrez, J. A., Rada, P. et al., Resveratrol treatment restores peripheral insulin sensitivity in diabetic mice in a sirt1-independent manner. Mol. Nutr. Food Res. 2015, 59, 1431–1442.
33. Karlsson, H. K., Zierath, J. R., Insulin signaling and glucose transport in insulin resistant human skeletal muscle. Cell Biochem. Biophys. 2007, 48, 103–113.
34. Tanti, J. F., Jager, J., Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr. Opin. Pharmacol. 2009, 9, 753–762.
35. Kido, Y., Burks, D. J., Withers, D., Bruning, J. C. et al., Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J. Clin. Invest. 2000, 105, 199–205.
36. Xiao, J., Xing, F., Huo, J., Fung, M. L. et al., Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis model. Sci. Rep-UK 2014, 4, 5587/1–12.
37. Kim, S. J., DeStefano, M. A., Oh, W. J., Wu, C. C. et al., mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8. Mol. Cell 2012, 48, 875–887.
38. Werner, E. D., Lee, J., Hansen, L., Yuan, M. et al., Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302. J Biol. Chem. 2004, 279, 35298–35305.
39. Scazzocchio, B., Varì, R., Filesi, C., Gaudio, I. D. et al., Protocatechuic acid activates key components of insulin signaling pathway mimicking insulin activity. Mol. Nutr. Food Res. 2015, 59, 1472–1481.
40. Liang, L., Chen, J., Zhan, L., Lu, X. et al., Endoplasmic reticulum stress impairs insulin receptor signaling in the brains of obese rats. PloS One 2015, 10, e0126384.
41. Sabatini, D. M., mTOR and cancer: insights into a complex relationship. Nat. Rev. Cancer 2006, 6, 729–734.
42. Wullschleger, S., Loewith, R., Hall, M. N., TOR signaling in growth and metabolism. Cell 2006, 124, 471–484.
43. Medeiros, C., Frederico, M. J., da Luz, G., Pauli, J. R. et al., Exercise training reduces insulin resistance and upregulates the mTOR/p70S6k pathway in cardiac muscle of diet-induced obesity rats. J. Cell. Physiol. 2011, 226, 666–674.
44. Ai, D., Chen, C., Han, S., Ganda, A. et al., Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice. J. Clin. Invest. 2012, 122, 1262–1270.
45. Li, J., Matye, D. J., Li, T., Insulin resistance induces posttranslational hepatic Sortilin 1 degradation in mice. J. Biol. Chem. 2015, 290, 11526–11536.
46. Kamagate, A., Qu, S., Perdomo, G., Su, D. et al., FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J. Clin. Invest. 2008, 118, 2347–2364.
47. Altomonte, J., Cong, L., Harbaran, S., Richter, A. et al., Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. J. Clin. Invest. 2004, 114, 1493–1503.